Effect of Postdismissal Pharmacist Visits for Patients Using High-Risk Medications Joseph R. Herges, PharmD, BCPS, Lori B. Herges, PharmD, BCPS, Ross A. Dierkhising, MS, Kristin C. Mara, MS, Amanda Z. Davis, PharmD, BCACP, Kurt B. Angstman, MD Mayo Clinic Proceedings: Innovations, Quality & Outcomes Volume 2, Issue 1, Pages 4-9 (March 2018) DOI: 10.1016/j.mayocpiqo.2017.12.004 Copyright © 2017 Mayo Foundation for Medical Education and Research Terms and Conditions
Figure Cumulative incidence of readmission. Kaplan-Meier curves estimating the incidence of readmission after follow-up visit for the PCC group and the UC group. PCC = pharmacist and clinician collaborative; UC = usual care. Mayo Clinic Proceedings: Innovations, Quality & Outcomes 2018 2, 4-9DOI: (10.1016/j.mayocpiqo.2017.12.004) Copyright © 2017 Mayo Foundation for Medical Education and Research Terms and Conditions